Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02243397 · ClinicalTrials.gov registry record
Molecular and Cellular Analysis of Breast Cancer
A clinical trial of Breast - Female and Breast - Male, sponsored by Stanford University.
- Completed
- Registry status
- 145
- Enrollment target
- 1
- Study location
NCT02243397: Completed study of Breast - Female and Breast - Male, sponsored by Stanford University.
NCT02243397 is a study of Breast - Female and Breast - Male that has completed, run by Stanford University. The registered enrollment target is 145 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02243397, a study of Breast - Female and Breast - Male, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 145 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond to various treatments.
Conditions Studied
Study Locations (1)
California
- Stanford University Cancer Institute - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2014-09-10 |
| Est. Completion | 2021-04-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02243397
The ClinicalTrials.gov registry entry for NCT02243397 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast - Female appearing as the primary indexed condition, and to 0 interventions.
NCT02243397 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02243397 about?
NCT02243397 is a clinical study titled "Molecular and Cellular Analysis of Breast Cancer". The purpose of the study is to investigate the different types and subtypes of cells found in breast tumors. The investigators will do this using a variety of molecular analysis tools that may allow for improved tests. The different types of cells in breast cancer impacts the way individuals respond...
What is the current status of trial NCT02243397?
This trial is currently completed. The enrollment target is 145 participants. The study started on 2014-09-10. Estimated completion is 2021-04-19.
What conditions does trial NCT02243397 study?
This clinical trial studies the following conditions: Breast - Female, Breast - Male.
Who is sponsoring clinical trial NCT02243397?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02243397 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast - Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.